Medicine and Dentistry
Pediatrics
100%
COVID-19
81%
Adolescent
35%
Tuberculosis
29%
Mantoux Test
28%
Polymerase Chain Reaction
26%
Prevalence
23%
Patient Referral
23%
Tuberculosis Diagnosis
22%
Symptom
22%
Nutritional Status
21%
Mycobacterium Tuberculosis
16%
Serositis
15%
Septic Shock
15%
Sepsis
15%
Cost-Effectiveness Analysis
13%
Latent Tuberculosis
13%
Health Care Cost
13%
Tuberculous Spondylitis
13%
Drug Resistant Epilepsy
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Postcovid Syndrome
13%
Miliary Tuberculosis
13%
Gastroesophageal Reflux
13%
Plasminogen Activator Inhibitor-1
13%
Clinical Feature
13%
Retrospective Cohort Study
13%
Hemodialysis
13%
Epileptic Seizure
13%
Pulmonary Hypertension
13%
Randomized Controlled Trial
13%
Substitution Therapy
13%
Drug Resistant Tuberculosis
13%
Inotropism
13%
Drug Therapy
13%
Household
13%
End Stage Renal Disease
13%
Radiological Finding
13%
Radiology
13%
Childhood Tuberculosis
13%
Fatality
11%
Primary Health Care
11%
Medical Record
11%
Pediatrics Patient
10%
Lung Tuberculosis
9%
Cross Sectional Study
9%
Disease
9%
Quality of Life
8%
Lymphadenopathy
8%
Disseminated Intravascular Coagulation
6%
Keyphrases
Indonesia
79%
COVID-19
47%
Pediatric
45%
Pediatric COVID-19
40%
Indonesian
28%
Data Registry
26%
Tuberculosis
23%
Tuberculosis Infection
16%
COVID-19 Pandemic
16%
Clinical Outcomes
16%
Pediatric Sepsis
15%
Clinical Features
15%
Tertiary Referral Hospital
15%
Case Fatality Rate
14%
Clinical Manifestations
14%
Multisystem Inflammatory Syndrome in children (MIS-C)
14%
Pediatric Patients
14%
Incomplete Information
13%
Vasoactive-inotropic Score
13%
School Reopening
13%
Pediatric Septic Shock
13%
Substitution Therapy
13%
Randomised Controlled Trial Protocol
13%
Disseminated Tuberculosis
13%
Tuberculosis Spondylitis
13%
Plasminogen Activator inhibitor-1 (PAI-1)
13%
Lessons Learned
13%
Household Contacts
13%
Tuberculosis in children
13%
Clinical Prognosis
13%
Tertiary Hospital
13%
Inactivated COVID-19 Vaccine
13%
HBsAg-positive Mothers
13%
Screening Process
13%
Gastroesophageal Reflux Disease Questionnaire
13%
Safety Profile
13%
Children under Five Years
13%
Long COVID
13%
Stool Test
13%
Ethiopia
13%
Cost-effectiveness Analysis
13%
Cut-off Score
13%
Parent Perspectives
13%
Drug-resistant Epilepsy
13%
Malaysian Adults
13%
Adverse Events Following Immunization
13%
Tuberculosis Prevalence
13%
Polymerase Chain Reaction Assay
13%
Antiseizure Medication
13%
Xpert Ultra
13%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Feature
40%
Disease
38%
Symptom
30%
Tuberculosis
29%
Adverse Event
26%
Coronavirinae
25%
Comorbidity
21%
Prevalence
21%
Coughing
19%
Retrospective Study
18%
Infection
16%
Normal Human
16%
Cross-Sectional Study
16%
Inflammation
15%
Latent Tuberculosis
13%
Drug Resistant Epilepsy
13%
Abdominal Pain
13%
Case Fatality Rate
13%
Tree
13%
Base
13%
SARS Coronavirus
13%
Randomized Controlled Trial
13%
Miliary Tuberculosis
13%
COVID-19 Vaccine
13%
Sepsis
13%
Tuberculous Spondylitis
13%
Plasminogen Activator Inhibitor 1
13%
Midazolam
13%
Down Syndrome
13%
Chloramphenicol
13%
Ampicillin
13%
Antibiotics
13%
Influenza
13%
Flu Like Syndrome
13%
Respiratory Tract Disease
13%
Influenza A
13%
Sinusitis
13%
HIV
13%
Influenza B
13%
Fatality
11%
Disseminated Intravascular Clotting
6%
Ketorolac Trometamol
6%
Inactivated Vaccine
5%
Lung Tuberculosis
5%
Rhinorrhea
5%
Influenza Virus
5%
Myalgia
5%
Tuberculin
5%
